161 related articles for article (PubMed ID: 22095369)
1. Effect of telavancin (Vibativ) on routine coagulation test results.
Gosselin R; Dager W; Roberts A; Freeman L; Gandy L; Gregg J; Dwyre D
Am J Clin Pathol; 2011 Dec; 136(6):848-54. PubMed ID: 22095369
[TBL] [Abstract][Full Text] [Related]
2. Effects of telavancin on coagulation test results.
Barriere SL; Goldberg MR; Janc JW; Higgins DL; Macy PA; Adcock DM
Int J Clin Pract; 2011 Jul; 65(7):784-9. PubMed ID: 21564449
[TBL] [Abstract][Full Text] [Related]
3. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
Lindahl TL; Baghaei F; Blixter IF; Gustafsson KM; Stigendal L; Sten-Linder M; Strandberg K; Hillarp A;
Thromb Haemost; 2011 Feb; 105(2):371-8. PubMed ID: 21103660
[TBL] [Abstract][Full Text] [Related]
4. Influence of 8 and 24-h storage of whole blood at ambient temperature on prothrombin time, activated partial thromboplastin time, fibrinogen, thrombin time, antithrombin and D-dimer.
Kemkes-Matthes B; Fischer R; Peetz D
Blood Coagul Fibrinolysis; 2011 Apr; 22(3):215-20. PubMed ID: 21297453
[TBL] [Abstract][Full Text] [Related]
5. Effect of freezing plasma at -20°C for 2 weeks on prothrombin time, activated partial thromboplastin time, dilute Russell viper venom time, activated protein C resistance, and D-dimer levels.
Foshat M; Bates S; Russo W; Huerta A; Albright K; Giddings K; Indrikovs A; Qian YW
Clin Appl Thromb Hemost; 2015 Jan; 21(1):41-7. PubMed ID: 24842886
[TBL] [Abstract][Full Text] [Related]
6. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
7. Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers.
Ero MP; Harvey NR; Harbert JL; Janc JW; Chin KH; Barriere SL
J Thromb Thrombolysis; 2014; 38(2):235-40. PubMed ID: 24132401
[TBL] [Abstract][Full Text] [Related]
8. Pitfalls in the assessment of disseminated intravascular coagulation in patients on dabigatran.
Kanda GS; Ho WK; Rodrigues C; Bousounis A; Hogan C
Pathology; 2021 Aug; 53(5):623-627. PubMed ID: 33526243
[TBL] [Abstract][Full Text] [Related]
9. Interaction of daptomycin with two recombinant thromboplastin reagents leads to falsely prolonged patient prothrombin time/International Normalized Ratio results.
Webster PS; Oleson FB; Paterson DL; Arkin CF; Mangili A; Craven DE; Adcock DM; Lindfield KC; Knapp AG; Martone WJ
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):32-8. PubMed ID: 18180613
[TBL] [Abstract][Full Text] [Related]
10. Influence of fibrinogen degradation products on thrombin time, activated partial thromboplastin time and prothrombin time of canine plasma.
Mischke R; Wolling H
Haemostasis; 2000; 30(3):123-30. PubMed ID: 11014962
[TBL] [Abstract][Full Text] [Related]
11. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
[TBL] [Abstract][Full Text] [Related]
12. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
13. Effects of Oritavancin on Coagulation Tests in the Clinical Laboratory.
Belley A; Robson R; Francis JL; Adcock DM; Tiefenbacher S; Rubino CM; Moeck G; Sylvester D; Dudley MN; Loutit J
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27956417
[TBL] [Abstract][Full Text] [Related]
14. Analysis of coagulation parameters in the early period after kidney transplantation.
Pawlicki J; Cierpka L; Król R; Ziaja J
Transplant Proc; 2007 Nov; 39(9):2754-5. PubMed ID: 18021978
[TBL] [Abstract][Full Text] [Related]
15. Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
Becker RC; Alexander JH; Newby LK; Yang H; Barrett Y; Mohan P; Wang J; Harrington RA; Wallentin LC
Thromb Haemost; 2010 Nov; 104(5):976-83. PubMed ID: 20806117
[TBL] [Abstract][Full Text] [Related]
16. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
Arnout J; Meijer P; Vermylen J
Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
[TBL] [Abstract][Full Text] [Related]
17. Effects of hirudin on activated partial thromboplastin time determined with ten different reagents.
Tripodi A; Chantarangkul V; Arbini AA; Moia M; Mannucci PM
Thromb Haemost; 1993 Aug; 70(2):286-8. PubMed ID: 8236136
[TBL] [Abstract][Full Text] [Related]
18. Monitoring direct thrombin inhibitors with a plasma diluted thrombin time.
Love JE; Ferrell C; Chandler WL
Thromb Haemost; 2007 Jul; 98(1):234-42. PubMed ID: 17598018
[TBL] [Abstract][Full Text] [Related]
19. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
20. A comparison of INRs after local calibration of thromboplastin international sensitivity indexes.
McGlasson DL
Clin Lab Sci; 2002; 15(2):91-5. PubMed ID: 12776770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
